Obama’s impact on care delivery goes beyond ACA

After President Barack Obama makes way for President-elect Donald Trump on Jan. 20, the Affordable Care Act (ACA) may go away—but his changes to the delivery system for healthcare will be harder to roll back.

In part of a New York Times series on Obama’s legacy, reporters Abby Goodnough and Robert Pear examine how healthcare has begun its transition away from fee-for-service models towards value-based care.

“I don’t know who could be against it: higher quality and lower cost,” said Ryan C. Kitchell, an executive vice president and the chief administrative officer of IU Health, the largest health provider in Indiana.

The transformation has come with consolidation into larger health systems, benefitting large organizations like IU Health as they’ve acquired smaller practices. There are also complaints about the complexity of this new risk-based approach and the new systems of quality measures.

“It may be good in theory,” said John M. Thomas, MD, a primary care physician at an IU Health practice in Lafayette, Indiana. “But there are a lot of flaws.”

For more on hospital leaders and physicians who don’t want to see a return to pre-Obama norms in healthcare spending and care delivery, click on the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup